Bruker Corporation announced that its established CE-IVD marked FluoroType? SARS-CoV-2 varID Q real-time multiplexed PCR assay reliably detects all SARS-CoV-2 variants, and in addition is expected to also provide a clear indication of Omicron (B.1.1.529), recently declared a ?variant of concern? by the WHO. The FluoroType? SARS-CoV-2 varID Q also provides a viral load result according to WHO standard (IU/ml), as well as CP values and easy interpretation of mutations. The test is validated for use with nasopharyngeal and oropharyngeal swabs and contains reagents for 96 reactions. Sample extraction, amplification and PCR results are available in under 3-4 hours. FluoroType? SARS-CoV-2 varID Q can be run on the FluoroCycler? XT PCR instrument after sample preparation with the GenoXtract?fleXT system, which provides fully automated extraction and PCR set up. The results from the FluoroCycler? XT are analysed by the FluoroSoftware? delivering easy to read results and direct indication of mutations. Using the FluoroType? SARS-CoV-2 varID Q assay allows the user to run a screening tool for detecting SARS-CoV-2, viral load and an early indication of the Omicron variant.